STAT1 and osteosarcoma: In addition, reduced nuclear entry of STAT1 in TGF-β-treated Saos-2 and MG-63 cells was found by immunofluorescence staining (Fig. 3C), suggesting that TGF-β suppressed STAT1 activation in osteosarcoma cells.